# A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.

> **NCT01250756** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 321 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **BIOLOGICAL:** 7-pneumococcal conjugate vaccine (7vPnC)
- **BIOLOGICAL:** diphtheria, tetanus, and acellular pertussis vaccine (DTaP)
- **BIOLOGICAL:** DTaP

## Key facts

- **NCT ID:** NCT01250756
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2013-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01250756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01250756, "A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01250756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*